Made-in-China Valsartan Heart Drug Pulled From Chinese Hospitals Over Cancer Risks: Report

Worldwide recalls highlight defective, counterfeit drugs made in China

Chinese workers preparing to destroy fake medicines seized in Beijing, on March 14, 2013. The U.S. Food and Drug Administration announced on July 13, 2018 the recall of the heart medicine valsartan, made by Chinese firm Zhejiang Huahai, which was found to be contaminated by a carcinogen. STR/AFP/Getty Images

The Chinese communist regime’s health regulator announced the recall of made-in-China pharmaceutical valsartan, which is being subject to a recall in the United States and Europe.